Literature DB >> 30698289

Inhibition of microRNA-92a increases blood vessels and satellite cells in skeletal muscle but does not improve duchenne muscular dystrophy-related phenotype in mdx mice.

Mayank Verma1, Yoko Asakura2, Atsushi Asakura3.   

Abstract

INTRODUCTION: The vasculature and blood flow in muscle are perturbed in Duchenne muscular dystrophy (DMD) and its mdx mouse model. MicroRNA-92a (miR-92a) is enriched in endothelial cells, especially during ischemic injury.
METHODS: Because antagonizing miR-92a was shown to result in increased proliferation and migration of endothelial cells and recovery from ischemia, we assessed the effects of Antagomir-92a in vitro in muscle stem cell culture and in vivo in mdx mice.
RESULTS: miR-92a was found to be highly expressed in muscle endothelial cells and satellite cells. Treatment with Antagomir-92a increased capillary density and tissue perfusion, which was accompanied by an increase in satellite cells. However, Antagomir-92a-treated mdx mice showed no histological improvement and had worse muscle function. Antagomir-92a suppressed myogenic differentiation in satellite cell culture. DISCUSSION: AntagomiR-92a improves the vasculature but not the muscle in mdx mice, possibly due to its side effects on satellite cell differentiation. Muscle Nerve 59:594-594, 2019.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  zzm321990mdx mouse; Antagomir; endothelial cell; miR-92a; muscular dystrophy; satellite cell

Mesh:

Substances:

Year:  2019        PMID: 30698289      PMCID: PMC8710231          DOI: 10.1002/mus.26433

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  44 in total

1.  Inhibition of miR-92a increases endothelial proliferation and migration in vitro as well as reduces neointimal proliferation in vivo after vascular injury.

Authors:  Claudio Iaconetti; Alberto Polimeni; Sabato Sorrentino; Jolanda Sabatino; Gianluigi Pironti; Giovanni Esposito; Antonio Curcio; Ciro Indolfi
Journal:  Basic Res Cardiol       Date:  2012-08-14       Impact factor: 17.165

2.  Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice.

Authors:  V M Chapman; D R Miller; D Armstrong; C T Caskey
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

3.  Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice.

Authors:  Alessandra Sacco; Foteini Mourkioti; Rose Tran; Jinkuk Choi; Michael Llewellyn; Peggy Kraft; Marina Shkreli; Scott Delp; Jason H Pomerantz; Steven E Artandi; Helen M Blau
Journal:  Cell       Date:  2010-12-09       Impact factor: 41.582

4.  Flow (shear stress)-induced endothelium-dependent dilation is altered in mice lacking the gene encoding for dystrophin.

Authors:  L Loufrani; K Matrougui; D Gorny; M Duriez; I Blanc; B I Lévy; D Henrion
Journal:  Circulation       Date:  2001-02-13       Impact factor: 29.690

5.  MicroRNA-92a negatively regulates Toll-like receptor (TLR)-triggered inflammatory response in macrophages by targeting MKK4 kinase.

Authors:  Lihua Lai; Yinjing Song; Yang Liu; Qingyun Chen; Quan Han; Weilin Chen; Ting Pan; Yuanyuan Zhang; Xuetao Cao; Qingqing Wang
Journal:  J Biol Chem       Date:  2013-01-25       Impact factor: 5.157

Review 6.  MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles.

Authors:  Eva van Rooij; Eric N Olson
Journal:  Nat Rev Drug Discov       Date:  2012-10-19       Impact factor: 84.694

7.  MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice.

Authors:  Angelika Bonauer; Guillaume Carmona; Masayoshi Iwasaki; Marina Mione; Masamichi Koyanagi; Ariane Fischer; Jana Burchfield; Henrik Fox; Carmen Doebele; Kisho Ohtani; Emmanouil Chavakis; Michael Potente; Marc Tjwa; Carmen Urbich; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Science       Date:  2009-05-21       Impact factor: 47.728

8.  Inhibition of microRNA miR-92a induces apoptosis and inhibits cell proliferation in human acute promyelocytic leukemia through modulation of p63 expression.

Authors:  Mohammadreza Sharifi; Rasoul Salehi; Yousof Gheisari; Mohammad Kazemi
Journal:  Mol Biol Rep       Date:  2014-01-31       Impact factor: 2.316

9.  Myofiber-specific TEAD1 overexpression drives satellite cell hyperplasia and counters pathological effects of dystrophin deficiency.

Authors:  Sheryl Southard; Ju-Ryoung Kim; SiewHui Low; Richard W Tsika; Christoph Lepper
Journal:  Elife       Date:  2016-10-11       Impact factor: 8.140

Review 10.  The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease.

Authors:  E Mogilyansky; I Rigoutsos
Journal:  Cell Death Differ       Date:  2013-12       Impact factor: 15.828

View more
  4 in total

1.  Assessment of the Diagnostic Potential of miR-29a-3p and miR-92a-3p as Circulatory Biomarkers in Acute Myeloid Leukemia.

Authors:  Marwa M Gado; Nahla O Mousa; M A Badawy; Maha A El Taweel; Ahmed Osman
Journal:  Asian Pac J Cancer Prev       Date:  2019-12-01

Review 2.  DNA nanotechnology approaches for microRNA detection and diagnosis.

Authors:  Arun Richard Chandrasekaran; Jibin Abraham Punnoose; Lifeng Zhou; Paromita Dey; Bijan K Dey; Ken Halvorsen
Journal:  Nucleic Acids Res       Date:  2019-11-18       Impact factor: 16.971

Review 3.  An Emerging Role for Epigenetics in Cerebral Palsy.

Authors:  Brigette Romero; Karyn G Robinson; Mona Batish; Robert E Akins
Journal:  J Pers Med       Date:  2021-11-12

4.  Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future.

Authors:  Agnieszka Łoboda; Józef Dulak
Journal:  Pharmacol Rep       Date:  2020-07-20       Impact factor: 3.024

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.